Joanna Stephens

Consultant Otolaryngologist

United Lincolnshire Hospitals NHS Trust, UK.

Latest Contribution

American Journal of Rhinology & Allergy cover image.

When to operate on a patient without chronic disease?

2 March 2022 | | Rhinology / Sinus | SNOT-22, balloon sinus dilation, endoscopic sinus surgery, management, sinusitis

As ENT surgeons, we spend a lot of time managing chronic rhinosinusitis, so a review and update on the management of the acute disease is always helpful. The standard medical treatment of antibiotics, nasal steroids and nasal decongestants are reported...

American Journal of Rhinology & Allergy cover image.

Serum biomarkers for CRSwNP

5 January 2022 | | ENT, Maxillofacial Surgery, Rhinology / Sinus | Lund Mackay score, Pentraxin-3, Sinonasal Outcome Test 22, biomarkers, chronic rhinosinusitis with nasal polyposis, immunoglobulin E, interleukin-17, polyposis recurrence, sinusitis

This cross-sectional comparative study looked at 50 patients with nasal polyps who, at the time of diagnosis, also had a blood test evaluating serum total IgE, IL-17 and Pentraxin-3. The study assesses whether these blood markers are useful in the...

American Journal of Otolaryngology cover image.

A new era in the treatment of recalcitrant nasal polyps?

8 November 2021 | | Laryngology / Swallowing / Voice, Rhinology / Sinus | IgE, SNOT-22, aspirin-exacerbated respiratory disease, chronic rhinosinusitis with nasal polyps, mild asthma, nasal polyps, omalizumab, quality of life, tissue eosinophilia, total nasal endoscopic polyp score

Chronic rhinosinusitis with nasal polyps (CRSwNP) can be difficult to treat effectively in patients with aggressive or recalcitrant disease. Omalizumab (Xolair) is a monoclonal anti-IgE antibody with proven benefits for patients with moderate/severe asthma and CRSwNP, but this study looks...